Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus Aug 12, 2010: Clinical and Regulatory PCR and Nucleic Acid Testing News

Premium

Myconostica said this week that its MycAssay Aspergillus and MycAssay Pneumocystis have received CE marking on the Roche LightCycler 2.0 and Stratagene Mx3000 series platforms.

The CE marking on these two platforms is in addition to existing CE marks for the tests on the Cepheid SmartCycler and Life Technologies Applied Biosystems 7500, Manchester, UK-based Myconostica said.

MycAssay Aspergillus detects Aspergillus spp. DNA in lower respiratory tract samples. Meantime, the MycAssay Pneumocystis detects Pneumocystis jirovecii DNA in lower respiratory tract samples. Both assays are designed to be used by qualified laboratory professionals and to aid physicians in diagnosing patients.

When used in conjunction with Myconostica's fungal DNA extraction system, MycXtra, a result can be obtained within three hours of sample receipt, Myconostica said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.